🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

FDA approves country’s first medicine made from marijuana statnews.com/2018/06/25/fda… via STAT

Bruins, Rangers players put competition aside for Slap Out Epilepsy event in Andover whdh.com/news/bruins-ra…

17/ Once again, here’s a link to our paper: nature.com/articles/s4146…. We hope you enjoy it.

Our new review for the 30th Anniversary issue of Neuron - The Meningeal Lymphatic System: A New Player in Neurophysiology cell.com/neuron/fulltex…

Wow. A whopping benefit of plasmapheresis and albumin in moderate Alzheimer in Phase 2b/3 trial. Note albumin fraction contains many other proteins prnewswire.com/news-releases/…

Congratulations- Jamie Maguire Appointed to Named Professorship now.tufts.edu/articles/jamie… via Tufts University

Haydon lab is hiring post docs for studies of glial neuron interactions contributing to Alzheimer’s disease and schizophrenia

Really interesting topic, indeed!!

The quality of Uber drivers is going way down. Pick up in the city for an in city drop off and the driver takes me out of the city so that we are battling rush hour traffic to get back Uner Uber Support

It was great to participate in the glia gordon conference in Ventura. So fun to see all the new investigators in the field and the energy of the trainees.

BIOGEN AND EISAI TO DISCONTINUE PHASE 3 ENGAGE AND EMERGE TRIALS OF ADUCANUMAB IN ALZHEIMER’S DISEASE - this is a huge setback for AD. We need more alternative therapeutic strategies

Heading home from SIRS 2019 in Orlando. Great to discuss astrocytic nicotinic receptors as a potential therapeutic target in schizophrenia. The weather, pool and hot tub weren’t bad either

Ida Lewis Distance Race Names Winners in Five Classes thenewportbuzz.com/ida-lewis-dist…

FDA approves new treatment for adults with partial-onset seizures fda.gov/news-events/pr…

Great things happening Sail for Epilepsy - Phil Haydon

It’s amazing how some who do not have epilepsy characterize and pigeon hole those of us with epilepsy

Thanks to Tufts’ Post-Baccalaureate Research Program, Sofia Corella is searching for predictive biomarkers for post-traumatic epilepsy ow.ly/5gYc50yquI9

Bob was my first employee and had been with me since 1986. This month he retires. The lab could not have achieved what it has without him. Thanks Bob

Antibodies in the brain trigger epilepsy: Study by the University of Bonn may enable new therapies against certain forms of the disease. bit.ly/2vLGeCh via Rheinische Friedrich-Wilhelms-Universität Bonn EurekAlert!

Stem Cells and Silk Make a New Way to Study the Brain now.tufts.edu/articles/stem-… via Tufts University